BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang B, Liu P, Zhou Y, Chen Z, He Y, Mo M, Dai G, Xia W, Du Y, Liu Y, Chen X. Dihydroartemisinin attenuates renal fibrosis through regulation of fibroblast proliferation and differentiation. Life Sciences 2019;223:29-37. [DOI: 10.1016/j.lfs.2019.03.020] [Cited by in Crossref: 19] [Cited by in F6Publishing: 27] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Li Q, Wu P, Xia Y, Liao D, Zuo Y, Wu J, Xia Q. Dihydroartemisinin-induced mitochondrial mRNA degradation and apoptosis in keloid fibroblasts. Chin Med J (Engl) 2022. [PMID: 35838528 DOI: 10.1097/CM9.0000000000001860] [Reference Citation Analysis]
2 Zhang Y, Mou Y, Zhang J, Suo C, Zhou H, Gu M, Wang Z, Tan R. Therapeutic Implications of Ferroptosis in Renal Fibrosis. Front Mol Biosci 2022;9:890766. [DOI: 10.3389/fmolb.2022.890766] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Hu T, Chen F, Chen D, Liang H. DNMT3a negatively regulates PTEN to activate the PI3K/AKT pathway to aggravate renal fibrosis. Cell Signal 2022;:110352. [PMID: 35523401 DOI: 10.1016/j.cellsig.2022.110352] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Hsieh YH, Tsai JP, Ting YH, Hung TW, Chao WW. Rosmarinic acid ameliorates renal interstitial fibrosis by inhibiting the phosphorylated-AKT mediated epithelial-mesenchymal transition in vitro and in vivo. Food Funct 2022;13:4641-52. [PMID: 35373225 DOI: 10.1039/d2fo00204c] [Reference Citation Analysis]
5 Yi YC, Liang R, Chen XY, Fan HN, Chen M, Zhang J, Zhu JS. Dihydroartemisinin Suppresses the Tumorigenesis and Cycle Progression of Colorectal Cancer by Targeting CDK1/CCNB1/PLK1 Signaling. Front Oncol 2021;11:768879. [PMID: 34796115 DOI: 10.3389/fonc.2021.768879] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Anibogwu R, Jesus K, Pradhan S, Pashikanti S, Mateen S, Sharma K. Extraction, Isolation and Characterization of Bioactive Compounds from Artemisia and Their Biological Significance: A Review. Molecules 2021;26:6995. [PMID: 34834086 DOI: 10.3390/molecules26226995] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
7 Xu H, Wu T, Huang L. Therapeutic and delivery strategies of phytoconstituents for renal fibrosis. Adv Drug Deliv Rev 2021;177:113911. [PMID: 34358538 DOI: 10.1016/j.addr.2021.113911] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
8 Zhang B, Chen X, Gan Y, Li BS, Wang KN, He Y. Dihydroartemisinin attenuates benign prostatic hyperplasia in rats by inhibiting prostatic epithelial cell proliferation. Ann Transl Med 2021;9:1246. [PMID: 34532383 DOI: 10.21037/atm-21-3296] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Zhang B, Chen X, Ru F, Gan Y, Li B, Xia W, Dai G, He Y, Chen Z. Liproxstatin-1 attenuates unilateral ureteral obstruction-induced renal fibrosis by inhibiting renal tubular epithelial cells ferroptosis. Cell Death Dis 2021;12:843. [PMID: 34511597 DOI: 10.1038/s41419-021-04137-1] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
10 Liu Y, Wang Z, Gan Y, Chen X, Zhang B, Chen Z, Liu P, Li B, Ru F, He Y. Curcumin attenuates prostatic hyperplasia caused by inflammation via up-regulation of bone morphogenetic protein and activin membrane-bound inhibitor. Pharm Biol 2021;59:1026-35. [PMID: 34357837 DOI: 10.1080/13880209.2021.1953539] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Hao J, Liu L, Liu Z, Chen G, Xiong Y, Wang X, Ma X, Xu Q. Aldosterone Induces the Proliferation of Renal Tubular Epithelial Cells In Vivo but Not In Vitro. J Renin Angiotensin Aldosterone Syst 2021;2021:9943848. [PMID: 34386059 DOI: 10.1155/2021/9943848] [Reference Citation Analysis]
12 Wang Z, Chen Z, Li B, Zhang B, Du Y, Liu Y, He Y, Chen X. Curcumin attenuates renal interstitial fibrosis of obstructive nephropathy by suppressing epithelial-mesenchymal transition through inhibition of the TLR4/NF-кB and PI3K/AKT signalling pathways. Pharm Biol 2020;58:828-37. [PMID: 32866059 DOI: 10.1080/13880209.2020.1809462] [Cited by in Crossref: 10] [Cited by in F6Publishing: 26] [Article Influence: 10.0] [Reference Citation Analysis]
13 Feng YL, Wang WB, Ning Y, Chen H, Liu P. Small molecules against the origin and activation of myofibroblast for renal interstitial fibrosis therapy. Biomed Pharmacother 2021;139:111386. [PMID: 34243594 DOI: 10.1016/j.biopha.2021.111386] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
14 Wang Y, Gao G, Wu Y, Wang Y, Wu X, Zhou Q. S100A4 Silencing Facilitates Corneal Wound Healing After Alkali Burns by Promoting Autophagy via Blocking the PI3K/Akt/mTOR Signaling Pathway. Invest Ophthalmol Vis Sci 2020;61:19. [PMID: 32926102 DOI: 10.1167/iovs.61.11.19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
15 Deng W, Wei X, Dong Z, Zhang J, Huang Z, Na N. Identification of fibroblast activation-related genes in two acute kidney injury models. PeerJ 2021;9:e10926. [PMID: 33777519 DOI: 10.7717/peerj.10926] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Wang X, Song W, Zhang F, Huang R. Dihydroartemisinin Inhibits TGF-β-Induced Fibrosis in Human Tenon Fibroblasts via Inducing Autophagy. Drug Des Devel Ther 2021;15:973-81. [PMID: 33688170 DOI: 10.2147/DDDT.S280322] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Feng Y, Zhao Y, Li Y, Peng T, Kuang Y, Shi X, Wang G, Peng F, Yu C. Inhibition of Fibroblast Activation in Uterine Leiomyoma by Components of Rhizoma Curcumae and Rhizoma Sparganii. Front Public Health 2021;9:650022. [PMID: 33732680 DOI: 10.3389/fpubh.2021.650022] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
18 Dolivo D, Weathers P, Dominko T. Artemisinin and artemisinin derivatives as anti-fibrotic therapeutics. Acta Pharm Sin B 2021;11:322-39. [PMID: 33643815 DOI: 10.1016/j.apsb.2020.09.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 14.0] [Reference Citation Analysis]
19 Chen P, Zhang Z, Chen X. Overexpression of PKMYT1 Facilitates Tumor Development and Is Correlated with Poor Prognosis in Clear Cell Renal Cell Carcinoma. Med Sci Monit 2020;26:e926755. [PMID: 33024069 DOI: 10.12659/MSM.926755] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
20 Cheng L, Tu C, Min Y, He D, Wan S, Xiong F. MiR-194 targets Runx1/Akt pathway to reduce renal fibrosis in mice with unilateral ureteral obstruction. Int Urol Nephrol 2020;52:1801-8. [PMID: 32661617 DOI: 10.1007/s11255-020-02544-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
21 Wang Y, Wang Y, You F, Xue J. Novel use for old drugs: The emerging role of artemisinin and its derivatives in fibrosis. Pharmacological Research 2020;157:104829. [DOI: 10.1016/j.phrs.2020.104829] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
22 Lei Z, Yang Y, Liu S, Lei Y, Yang L, Zhang X, Liu W, Wu H, Yang C, Guo J. Dihydroartemisinin ameliorates dextran sulfate sodium induced inflammatory bowel diseases in mice. Bioorg Chem 2020;100:103915. [PMID: 32450383 DOI: 10.1016/j.bioorg.2020.103915] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
23 Xia M, Liu D, Liu Y, Liu H. The Therapeutic Effect of Artemisinin and Its Derivatives in Kidney Disease. Front Pharmacol 2020;11:380. [PMID: 32296335 DOI: 10.3389/fphar.2020.00380] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
24 Xia M, Liu D, Tang X, Liu Y, Liu H, Liu Y, Chen G, Liu H. Dihydroartemisinin inhibits the proliferation of IgAN mesangial cells through the mTOR signaling pathway. Int Immunopharmacol 2020;80:106125. [PMID: 31931362 DOI: 10.1016/j.intimp.2019.106125] [Cited by in Crossref: 6] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
25 Zhang B, Chen X, Xie C, Chen Z, Liu Y, Ru F, He Y. Leptin promotes epithelial-mesenchymal transition in benign prostatic hyperplasia through downregulation of BAMBI. Exp Cell Res 2020;387:111754. [PMID: 31805276 DOI: 10.1016/j.yexcr.2019.111754] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
26 Li N, Sun W, Zhou X, Gong H, Chen Y, Chen D, Xiang F. Dihydroartemisinin Protects against Dextran Sulfate Sodium-Induced Colitis in Mice through Inhibiting the PI3K/AKT and NF-κB Signaling Pathways. Biomed Res Int 2019;2019:1415809. [PMID: 31781591 DOI: 10.1155/2019/1415809] [Cited by in Crossref: 9] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
27 Du H, Zhao Q, Zang H, Chang C, Li X. Artemisinin attenuates the development of atherosclerotic lesions by the regulation of vascular smooth muscle cell phenotype switching. Life Sciences 2019;237:116943. [DOI: 10.1016/j.lfs.2019.116943] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]